Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Prepaid Assets (2019 - 2025)

Revolution Medicines has reported Prepaid Assets over the past 7 years, most recently at $49.4 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $49.4 million for Q4 2025, up 28.76% from a year ago — trailing twelve months through Dec 2025 was $49.4 million (up 28.76% YoY), and the annual figure for FY2025 was $49.4 million, up 28.76%.
  • Prepaid Assets for Q4 2025 was $49.4 million at Revolution Medicines, up from $46.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for RVMD hit a ceiling of $49.4 million in Q4 2025 and a floor of $6.8 million in Q4 2021.
  • Median Prepaid Assets over the past 5 years was $15.6 million (2022), compared with a mean of $21.6 million.
  • Biggest five-year swings in Prepaid Assets: crashed 36.88% in 2023 and later skyrocketed 237.02% in 2024.
  • Revolution Medicines' Prepaid Assets stood at $6.8 million in 2021, then skyrocketed by 55.66% to $10.6 million in 2022, then surged by 137.22% to $25.1 million in 2023, then skyrocketed by 52.89% to $38.3 million in 2024, then grew by 28.76% to $49.4 million in 2025.
  • The last three reported values for Prepaid Assets were $49.4 million (Q4 2025), $46.0 million (Q3 2025), and $39.3 million (Q2 2025) per Business Quant data.